Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 2
2015 1
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Sociodemographic and clinical characteristics associated with vitamin D status in newly diagnosed pediatric cancer patients.
Aristizabal P, Sherer M, Perdomo BP, Castelao E, Thornburg CD, Proudfoot J, Jacobs E, Newfield RS, Zage P, Roberts W, Martinez ME. Aristizabal P, et al. Among authors: perdomo bp. Pediatr Hematol Oncol. 2020 May;37(4):314-325. doi: 10.1080/08880018.2020.1721629. Epub 2020 Mar 10. Pediatr Hematol Oncol. 2020. PMID: 32153233 Free PMC article. Clinical Trial.
Improving Pediatric Neuro-Oncology Survival Disparities in the United States-Mexico Border Region: A Cross-Border Initiative Between San Diego, California, and Tijuana, Mexico.
Aristizabal P, Burns LP, Kumar NV, Perdomo BP, Rivera-Gomez R, Ornelas MA, Gonda D, Malicki D, Thornburg CD, Roberts W, Levy ML, Crawford JR. Aristizabal P, et al. Among authors: perdomo bp. JCO Glob Oncol. 2020 Nov;6:1791-1802. doi: 10.1200/GO.20.00377. JCO Glob Oncol. 2020. PMID: 33216645 Free PMC article.
Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration.
Salzberg-Brenhouse HC, Chen EY, Emerich DF, Baldwin S, Hogeland K, Ranelli S, Lafreniere D, Perdomo B, Novak L, Kladis T, Fu K, Basile AS, Kordower JH, Bartus RT. Salzberg-Brenhouse HC, et al. Among authors: perdomo b. J Pharmacol Exp Ther. 2003 Jul;306(1):218-28. doi: 10.1124/jpet.103.049700. Epub 2003 Apr 3. J Pharmacol Exp Ther. 2003. PMID: 12676885
Bradykinin modulation of tumor vasculature: II. activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumors.
Emerich DF, Dean RL, Snodgrass P, Lafreniere D, Agostino M, Wiens T, Xiong H, Hasler B, Marsh J, Pink M, Kim BS, Perdomo B, Bartus RT. Emerich DF, et al. Among authors: perdomo b. J Pharmacol Exp Ther. 2001 Feb;296(2):632-41. J Pharmacol Exp Ther. 2001. PMID: 11160652